pqq cofactor has been researched along with Fetal Growth Restriction in 1 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mattern, J | 1 |
| Gemmell, A | 1 |
| Allen, PE | 1 |
| Mathers, KE | 1 |
| Regnault, TRH | 1 |
| Stansfield, BK | 1 |
1 other study available for pqq cofactor and Fetal Growth Restriction
| Article | Year |
|---|---|
Oral pyrroloquinoline quinone (PQQ) during pregnancy increases cardiomyocyte endowment in spontaneous IUGR guinea pigs.
Topics: Animals; Antioxidants; Female; Fetal Growth Retardation; Guinea Pigs; Myocytes, Cardiac; Oxidation-R | 2023 |